Drug Information Update - FDA Webinar: Webinar Draft GFI On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability – July 25, 2013

The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

---

On July 25, 2013, from 11:00AM-12:30PM (EDT), FDA will present a webinar on a new draft guidance entitled "Draft Guidance For Industry On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability."

The webinar will provide an opportunity to learn about the guidance from individuals involved in its preparation. It is also intended to encourage the submission of questions or comments while the guidance is still in draft form.

 

Questions may be submitted online during the webinar and will be addressed as time permits. All questions should also be submitted to docket so that they can be formally processed by FDA.

 

DRAFT GFI:

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM354468.pdf 

 

FR NOTICE

http://www.gpo.gov/fdsys/pkg/FR-2013-05-31/pdf/2013-12922.pdf 

For more information please visit: FDA Webinar